NanoMed Systems
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $320M
Overview
A nanotechnology company developing targeted drug delivery systems and combination medical devices.
Drug DeliveryOncologyChronic Disease
Technology Platform
Proprietary nanoparticle and polymer-based platforms for targeted, sustained, or localized delivery of a wide range of therapeutic agents.
Funding History
1Total raised:$320M
Series C$320M
Opportunities
Potential for steady royalty revenue if multiple partnered programs using its platform advance to market and achieve commercial success.
Risk Factors
Dependent on the success of partners' underlying drug molecules; a clinical failure of a partner's drug ends the associated revenue stream.
Competitive Landscape
Competes with other drug delivery technology firms and the in-house formulation teams of large pharmaceutical partners.